PH21400A - Improved formulation of antiinflammatory drugs - Google Patents

Improved formulation of antiinflammatory drugs

Info

Publication number
PH21400A
PH21400A PH32913A PH32913A PH21400A PH 21400 A PH21400 A PH 21400A PH 32913 A PH32913 A PH 32913A PH 32913 A PH32913 A PH 32913A PH 21400 A PH21400 A PH 21400A
Authority
PH
Philippines
Prior art keywords
guanidino
imidazolyl
thiazole
methyl
antiinflammatory drugs
Prior art date
Application number
PH32913A
Other languages
English (en)
Inventor
Lamattina John Lawrence
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of PH21400A publication Critical patent/PH21400A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Electron Beam Exposure (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Radiation-Therapy Devices (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Indole Compounds (AREA)
PH32913A 1984-10-11 1985-10-10 Improved formulation of antiinflammatory drugs PH21400A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US65975284A 1984-10-11 1984-10-11
US06/765,415 US4636498A (en) 1984-10-11 1985-08-15 Formulation of antiinflammatory drugs

Publications (1)

Publication Number Publication Date
PH21400A true PH21400A (en) 1987-10-15

Family

ID=27097890

Family Applications (1)

Application Number Title Priority Date Filing Date
PH32913A PH21400A (en) 1984-10-11 1985-10-10 Improved formulation of antiinflammatory drugs

Country Status (16)

Country Link
US (1) US4636498A (da)
EP (1) EP0178121B1 (da)
CN (1) CN1011196B (da)
AT (1) ATE53492T1 (da)
AU (1) AU558668B2 (da)
CA (1) CA1251138A (da)
DE (1) DE3578125D1 (da)
DK (1) DK165964C (da)
EG (1) EG17529A (da)
FI (1) FI853948L (da)
GR (1) GR852459B (da)
IE (1) IE58740B1 (da)
IL (1) IL76647A0 (da)
NZ (1) NZ213756A (da)
PH (1) PH21400A (da)
PT (1) PT81280B (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1196307B (it) * 1984-10-22 1988-11-16 Chiesi Farma Spa Formulazioni farmaceutiche acquose di piroxicam monoidrato
US5260333A (en) * 1986-08-08 1993-11-09 Bristol Myers Squibb Company Effect of a combination of a terbutaline, diphenhydramine and ranitidine composition on gastrointestinal injury produced by nonsteroidal anti-inflammatory compositions
GB8625325D0 (en) * 1986-10-22 1986-11-26 Glaxo Group Ltd Chemical compounds
NL8902338A (nl) * 1988-09-20 1990-04-17 Glaxo Group Ltd Farmaceutische preparaten.
WO1994028898A1 (en) * 1993-06-15 1994-12-22 Pfizer Inc. H2-antagonists as immune stimulants in bacterial infections of cattle or swine
US20060281775A1 (en) 2005-06-14 2006-12-14 Applied Pharmacy Services, Inc. Two-component pharmaceutical composition for the treatment of pain

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL6715112A (da) * 1966-11-21 1968-05-22
US4230717A (en) * 1978-12-29 1980-10-28 Lovelace Alan M Administrator Indomethacin-antihistamine combination for gastric ulceration control
GB2105193B (en) * 1981-09-04 1984-09-12 Glaxo Group Ltd Pharmaceutical compositions containing non-steroidal anti-inflammatory agents
BE894286A (fr) * 1981-09-04 1983-03-02 Glaxo Group Ltd Composition pharmaceutique contenant un medicament anti-inflammatoire systemique non steroidique et du 1-methyl-5-((3-(3-(1-piperidinylmethyl)phenoxy)-propyl)amino -1h-1,2,4-triazole-3-methanol ou un sel de ce compose
US4435396A (en) * 1982-05-10 1984-03-06 Pfizer Inc. Antiulcer 2-guanidino-4-(2-substituted-amino-4-imidazolyl)thiazoles and process therefor
US4447443A (en) * 1982-11-15 1984-05-08 Merck & Co., Inc. Anti-inflammatory/analgesic combination of α-fluoromethylhistidine and a selected non-steroidal anti-inflammatory drug (NSAID)

Also Published As

Publication number Publication date
IE852494L (en) 1987-02-15
DK165964B (da) 1993-02-22
IE58740B1 (en) 1993-11-03
EP0178121A2 (en) 1986-04-16
DK165964C (da) 1993-07-26
EG17529A (en) 1993-08-30
EP0178121B1 (en) 1990-06-13
CN1011196B (zh) 1991-01-16
AU4848585A (en) 1986-05-08
GR852459B (da) 1986-02-11
CN85107521A (zh) 1986-08-06
FI853948A7 (fi) 1986-04-12
AU558668B2 (en) 1987-02-05
PT81280A (en) 1985-11-01
US4636498A (en) 1987-01-13
FI853948A0 (fi) 1985-10-10
FI853948L (fi) 1986-04-12
IL76647A0 (en) 1986-02-28
ATE53492T1 (de) 1990-06-15
DE3578125D1 (de) 1990-07-19
DK463885A (da) 1986-04-12
EP0178121A3 (en) 1988-10-05
NZ213756A (en) 1988-11-29
PT81280B (pt) 1988-02-17
DK463885D0 (da) 1985-10-10
CA1251138A (en) 1989-03-14

Similar Documents

Publication Publication Date Title
GB2206788B (en) 5 ht-3 antagonist for the treatment or reduction of dependence
NO881697D0 (no) Verktoeyenhet, verktoeydeler og fremgangsmaate for sammensetting av delene.
HK33289A (en) An indole derivative
BR1100546A (pt) Compostos e composições de piridil imidazol.
IT9047580A0 (it) Procedimento di trattamento di polveri inorganiche.
IT8919316A0 (it) Benzoderivati di composti eterociclici contenenti azoto.
MY106964A (en) Fused polycyclic compounds, compositions, methods of manufacture, and their use as paf antagonists, antihistamines and/or antiinflammatory agents.
ES8700666A1 (es) Procedimiento para la preparacion de derivados de 2-(piridi-lalquilenosulfinil)benzimidazoles n-substituidos como agen- tes antisecretorios gastricos
IE880061L (en) 1,2,4,5-tetrasubstituted benzene derivatives
FI941776A7 (fi) Menetelmä 1,2,4-tiadiatsolien valmistamiseksi
EG17529A (en) Improved formulation of antiinflammatory drugs
JPS6434967A (en) Heterocyclic compound, manufacture and pharmaceutical or veterinary composition having aromatase inhibition
HU9503453D0 (en) Heterocyclic chemistry
FI852743A7 (fi) Asetyleenisiä fenoksipropanolijohdannaisia ja farmaseuttisia koostumuksia hypertoniahoitamiseksi.
DK527685D0 (da) 5-(omega-phenethylamino-alkyl)-4,5,6,7-tetrahydro-thieno-(3,2-c)-pyridinderivater, fremgangsmaade til fremstilling af og laegemiddel indeholdende saadanne forbindelser
IT1233763B (it) Metodo per ottenere composti polverulenti altofondenti inorganici e composizioni metalliche.
IT8421342A0 (it) Composizioni e composti per il trattamento dell'adenoma prostatico.
FR2693368B1 (fr) Trépan perfectionné notamment pour chirurgie oculaire.
NO885640L (no) Framgangsmaate og sammensetninger for katodisk beskyttelse.
NO972450L (no) Substituerte 2-(fosfinyloksymetyl)-1,2,5-tiadiazolidin-3-on 1,1-dioksider og preparater og metode for anvendelse derav
NZ235455A (en) 2-(1,3-dioxan-2-yl)-4,5-diphenylimidazole derivatives and pharmaceutical compositions
NO910174L (no) Fremgangsmaate for sveising av plettert staal.
KR900007413A (ko) 에이즈 발병방지, 치료제 및 그 치료용 조성물
IT8920994A0 (it) Nuovi derivati imidazolici ad azione inibente l'enzima trombossanosintetasi.
IT8922064A0 (it) Elettrodo per l'emissione controllata di onde elettromagnetiche, particolarmente per apparecchiature termoterapeutiche